Impact of Antibiotic Administrative Restrictions on Trends in Antibiotic Resistance

Authors:

Abstract
In March 2001, in response to concerns about increasing resistance to fluoroquinolone (FQ) antibiotics, the Ontario Drug Benefit (ODB) program limited reimbursement of FQs to ODB beneficiaries defined as high risk or in whom other therapies are not tolerated.

This publication has 22 references indexed in Scilit: